MedTrace Logo

Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

NCT00998933 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2009-11-25

No results posted yet for this study

Summary

To further characterize the transfer potential of marketed testosterone gel and new 1.62% formulation.

Conditions

  • Hypogonadism

Interventions

DRUG

Testosterone gel 1.62%

5 grams applied topically to upper arms/shoulder and abdomen on Day 1

Sponsors & Collaborators

  • Solvay Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Global Clinical Director Solvay · Solvay Pharmaceuticals

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00998933 on ClinicalTrials.gov